Organization Overview
Historical Acquisition Tree
Alternative names
acetaminophen (tylenol) (2017)
aciclovir (zovirax) (2021)
amlodipine (norvasc) (2012)
aripiprazole (abilify) (2016)
candesartan (atacand) (2015)
celecoxib (celebrex) (2016)
clobetasol (dermovate) (2017)
clopidogrel (plavix) (2014)
darifenacin (enablex) (2017)
dolutegravir (tivicay) (2021)
donepezil (aricept) (2012)
duloxetine (Cymbalta) (2017)
efavirenz (sustiva) (2011)
emtricitabine (emtriva) (2014)
entacapone (comtan) (2017)
escitalopram (lexapro) (2012)
eszopiclone (lunesta) (2015)
famciclovir (famvir) (2012)
febuxostat (uloric) (2017)
fluocinonide (lidex) (2018)
hydrochlorothiazide (esidrix) (2012)
ibandronate (boniva) (2017)
irbesartan (avapro) (2012)
lamivudine (epivir) (2008)
lamivudine, nevirapine, and stavudine (2010)
levocetirizine (xyzal) (2016)
levofloxacin (levaquin) (2012)
levothyroxine (Synthroid) (2022)
lidocaine (xylocaine) (2020)
lopinavir (Kaletra) (2016)
losartan (cozaar) (2012)
memantine (namenda) (2015)
metformin (glucophage) (2015)
milnacipran (savella) (2018)
montelukast (singulair) (2014)
nevirapine (viramune) (2012)
niacin (2022)
nystatin (mycostatin) (2021)
olanzapine (zyprexa) (2014)
olmesartan (benicar) (2015)
oseltamivir (tamiflu) (2017)
pantoprazole (protonix) (2012)
pioglitazone (actos) (2013)
pramipexole (mirapex) (2012)
pregabalin (lyrica) (2016)
pyrazinamide (Aldinamide) (2020)
quetiapine (seroquel) (2016)
risedronate (actonel) (2015)
ritonavir (Norvir) (2016)
rivastigmine (exelon) (2014)
rizatriptan (maxalt) (2014)
sildenafil (viagra) (2013)
silodosin (rapaflo) (2018)
sodium chloride (2012)
stavudine (zerit) (2010)
tadalafil (cialis) (2019)
tamsulosin (flomax) (2017)
telmisartan (micardis) (2015)
tenofovir (viread) (2012)
tolterodine (detrol) (2015)
tramadol (Ultram) (2015)
triamcinolone (kenalog) (2018)
valsartan (diovan) (2013)
vardenafil (levitra) (2015)
venlafaxine (effexor) (2017)
zidovudine (retrovir) (2012)
ziprasidone (geodon) (2017)
zolmitriptan (zomig) (2015)
Tuberculosis (Phase 2)
Tuberculosis, Multidrug-Resistant (Phase 2)